Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nation-wide Consortium to Investigate Host Genetics of COVID-19

The coronavirus disease (COVID-19) pandemic has had a devastating effect worldwide, including in Japan (see https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html). Host genome differences between populations may influence disease severity. This may explain why Asians, including Japanese, may have a lower risk of death (Price-Haywood EG et al., 2020; Zeberg H et al., 2020). The Japan COVID-19 Task Force was established in early 2020 as a nationwide multicenter consortium. We collected and analyzed clinical specimens from patients in more than 70 institutions nationwide since February 2020 and reported the results of a genome-wide association study (Namkoong H et al., 2021).

Source: International Journal of Infectious Diseases - September 30, 2021 Category: Infectious Diseases Authors: Hiromu Tanaka, Ho Lee, Atsuho Morita, Ho Namkoong, Shotaro Chubachi, Hiroki Kabata, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Norihiro Harada, Tetsuya Ueda, Soichiro Ueda, Takashi Ishiguro, Ken Arimura, Fukuki Saito, Takashi Yoshiyama, Yasushi Nakano Tags: Short Communication Source Type: research